Smoking and adverse outcomes in patients With CKD: the Study of Heart and Renal Protection (SHARP)
Background<br/> The absolute and relative importance of smoking to vascular and nonvascular outcomes in people with chronic kidney disease (CKD), as well its relevance to kidney disease progression, is uncertain. <br/><br/>Study Design<br/> Observational study. <br/>&...
Main Authors: | Emberson, J, Staplin, N, Haynes, R, Herrington, W, Reith, C, Landray, M, Baigent, C, Cass, A, Fellström, B, Jiang, L, Kasiske, B, Krane, V, Levin, A, Walker, R, Wanner, C, Wheeler, D, SHARP Collaborative Group |
---|---|
Format: | Journal article |
Published: |
Elsevier
2016
|
Similar Items
-
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)
by: Staplin, N, et al.
Published: (2015) -
Evaluating the contribution of the cause of kidney disease to prognosis in ckd: Results from the Study of Heart and Renal Protection (SHARP)
by: Haynes, R, et al.
Published: (2014) -
Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP).
by: Haynes, R, et al.
Published: (2014) -
Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection.
by: Mafham, M, et al.
Published: (2017) -
Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP)
by: Herrington, WG, et al.
Published: (2023)